A federal judge is close to a issuing a surprise ruling that would block CVS's $69 billion acquisition of Aetna, the New York Post reports.
Executive slams short-seller Andrew Left's report.
Shortseller Andrew Left says Jumia's post IPO stock jump is built on fraud.
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
Goldman Sachs is paying top-of-the-market interest rates on regular savings accounts via its online bank. So CEO David Solomon used his testimony at a U.S. House of Representatives hearing to tout the offering -- with the CEOs of low-paying JPMorgan Chase and Bank of America sitting close by.
Tesla's CEO is encountering an experienced jurist on Thursday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.